A cost analysis of the diagnosis and treatment of malaria at public health facilities and communities in three districts in Rwanda

Table 8 Sensitivity analysis of uncertain parameters on the overall costs

Baseline total cost (USD^a)	Min	Max
Baseline total cost (USD^a)	622,860.78	645,372.68
Parameter	Low parameters estimate effect (USD^a)	High parameters estimate effect (USD^a)
Disease rate:
Low endemicity area	52,686	59,182
Moderate endemicity area	263,812	277,501
High endemicity area	1,544,794	1,583,129
Hospitalization in the ward:
At health centre:	622,380	664,128
At district hospital:	622,407	655,617
RDT^b	606,695	744,050
Blood smear
At health centre:	597,430	685,993
At district hospital:	622,841	645,545
ACT^c
6 × 1^d	614,174	752,363
6 × 4^e	609,406	1,026,020
Artesunate	620,485	649,575
Lowest and highest economic impact¹	549,169	1,343,601

^aUSD: United States Dollar; ^bRDT: Rapid diagnostic test, ^cACT: Artemisinin-based combination therapy; ^c6 × 1: dosage for children with 5 kg to < 15 kg body weight; ^d6 × 4: dosage for adult and children with > 35 kg body weight; ¹Lowest and highest economic impact: overall effect on total costs produced by varying all low cost and high-cost estimates simultaneously

ISSN: 1475-2875